86 related articles for article (PubMed ID: 15336653)
1. Potential utility of BimS as a novel apoptotic therapeutic molecule.
Yip KW; Li A; Li JH; Shi W; Chia MC; Rashid SA; Mocanu JD; Louie AV; Sanchez O; Huang D; Busson P; Yeh WC; Gilbert R; O'sullivan B; Gullane P; Liu FF
Mol Ther; 2004 Sep; 10(3):533-44. PubMed ID: 15336653
[TBL] [Abstract][Full Text] [Related]
2. A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy.
Chia MC; Shi W; Li JH; Sanchez O; Strathdee CA; Huang D; Busson P; Klamut HJ; Liu FF
Mol Ther; 2004 Jun; 9(6):804-17. PubMed ID: 15194047
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted gene therapy for nasopharyngeal carcinoma.
Li JH; Chia M; Shi W; Ngo D; Strathdee CA; Huang D; Klamut H; Liu FF
Cancer Res; 2002 Jan; 62(1):171-8. PubMed ID: 11782375
[TBL] [Abstract][Full Text] [Related]
4. Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.
Zuo Y; Wu J; Xu Z; Yang S; Yan H; Tan L; Meng X; Ying X; Liu R; Kang T; Huang W
PLoS One; 2011 May; 6(5):e19407. PubMed ID: 21573215
[TBL] [Abstract][Full Text] [Related]
5. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma.
Hui AB; Yue S; Shi W; Alajez NM; Ito E; Green SR; Frame S; O'Sullivan B; Liu FF
Clin Cancer Res; 2009 Jun; 15(11):3716-24. PubMed ID: 19470731
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
Weinrib L; Li JH; Donovan J; Huang D; Liu FF
Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
9. Potential efficacy of p16 gene therapy for EBV-positive nasopharyngeal carcinoma.
Li AA; Ng E; Shi W; Lee A; Chia M; Liu TJ; Huang D; O'Sullivan B; Gullane P; Liu FF
Int J Cancer; 2004 Jun; 110(3):452-8. PubMed ID: 15095314
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of targeted FasL in nasopharyngeal carcinoma.
Li JH; Shi W; Chia M; Sanchez-Sweatman O; Siatskas C; Huang D; Busson P; Klamut H; Yeh WC; Richardson C; O'Sullivan B; Gullane P; Neligan P; Medin J; Liu FF
Mol Ther; 2003 Dec; 8(6):964-73. PubMed ID: 14664799
[TBL] [Abstract][Full Text] [Related]
11. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice.
Lacy J; Loomis R; Grill S; Srimatkandada P; Carbone R; Cheng YC
Int J Cancer; 2006 Jul; 119(2):309-16. PubMed ID: 16477627
[TBL] [Abstract][Full Text] [Related]
12. Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy.
Mocanu JD; Yip KW; Alajez NM; Shi W; Li JH; Lunt SJ; Moriyama EH; Wilson BC; Milosevic M; Lo KW; van Rooijen N; Busson P; Bastianutto C; Liu FF
Mol Ther; 2007 May; 15(5):921-9. PubMed ID: 17356543
[TBL] [Abstract][Full Text] [Related]
13. Combination bcl-2 antisense and radiation therapy for nasopharyngeal cancer.
Yip KW; Mocanu JD; Au PY; Sleep GT; Huang D; Busson P; Yeh WC; Gilbert R; O'Sullivan B; Gullane P; Bastianutto C; Liu FF
Clin Cancer Res; 2005 Nov; 11(22):8131-44. PubMed ID: 16299246
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression.
Li-juan B; Bing L; Zhi L; Yang L; Ying-jie L
Pathol Res Pract; 2009; 205(12):828-37. PubMed ID: 19625133
[TBL] [Abstract][Full Text] [Related]
19. Combined use of adenoviral vector Ad5/F35-mediated APE1 siRNA enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in hepatoma cells in vitro and in vivo.
Cun Y; Zhang Q; Xiong C; Li M; Dai N; Zhang S; Wang D
Oncol Rep; 2013 Jun; 29(6):2197-204. PubMed ID: 23563597
[TBL] [Abstract][Full Text] [Related]
20. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
